Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness
Key facts
- Who runs it
- University of Maryland, Baltimore
- Where
- Baltimore, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 59 people enrolled
- Started
- 6 Sept 2022
- Ended
- 25 Mar 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- BecomeAnEX
- Usual Care
- Record updated
- 15 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Age 18 or greater
- Diagnosis of serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, or major depression)
- Current smoker [prior to admission, smoked at least one cigarette or small cigar per day in the past month (unless restricted, e.g. due to ER/hospital visit) and smoked at least 100 cigarettes lifetime]
- Interested in remaining quit after hospital discharge or quitting within the following 30 days
- Expected Internet use at least 3 times/week post-discharge and ownership of mobile device with text messaging plan post-discharge
- Discharge destination within 1-hour of SPH given that Aim 3 involves biochemical verification (carbon monoxide testing)
- Reading competence as demonstrated by a score of >= 37 on the Word Reading subtest of the Wide Range Achievement Test - 4th Edition (WRAT-4)168 to ensure the ability to engage in the intervention
Who cannot take part
- Homeless prior to admission or anticipated to be homeless at discharge
- Medical condition for which the use of nicotine replacement therapy (NRT) is contraindicated including pregnant, planning to become pregnant, or breastfeeding; within 4 weeks post myocardial infarction; severe arrhythmia, severe angina pectoris; peptic ulcer; severe renal failure; poorly controlled insulin-dependent diabetes; severely uncontrolled hypertension; peripheral vascular disease
- Intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness
- Discharge to a residential setting where smoking is prohibited
Where in United States
- Melanie BennettBaltimore, United States
- University of Maryland School of MedicineBaltimore, United States
About the trial
What the trial wants to find out
All patients with serious mental illness are abstinent while in the hospital for a psychiatric admission yet almost all return to smoking after discharge. The investigators propose to test a digital intervention adapted to the needs of SMI smokers and to being introduced in the inpatient psychiatric setting. Such an intervention could bridge the inpatient to outpatient gap in cessation services and will help people remain abstinent following hospital discharge.
The 2 groups in the trial
- BecomeAnEXTreatment being tested
Participants will have three individual meetings with a research staff person while they are in the hospital. At these meetings participants will answer questions about their smoking and interest in quitting, learn about BecomeAnEx, and register with the BecomeAnEx program so that they can use it when you leave the hospital. Participants will be given two weeks of nicotine replacement therapy when they leave the hospital. Participants will be asked to use BecomeAnEx as much as they want when they leave the hospital.
Treatment: BecomeAnEX and Usual Care
- Usual CareExisting treatment, for comparison
Brief individual counseling, NRT during the hospital stay and a prescription for NRT at discharge (consistent with standard hospital procedures), and referral to the MD quitline.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 15 July 2026